ABMT (Advanced BioMedical Technologies) Retained Earnings: $-10.82 Mil (As of Jul. 2021)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Advanced BioMedical Technologies Retained Earnings?

Advanced BioMedical Technologies ABMT Retained Earnings is $-10.82 Mil as of Jul. 2021.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Advanced BioMedical Technologies's retained earnings for the quarter that ended in Jul. 2021 was $-10.82 Mil.

Advanced BioMedical Technologies's quarterly retained earnings declined from Jan. 2021 ($-10.43 Mil) to Apr. 2021 ($-10.62 Mil) and declined from Apr. 2021 ($-10.62 Mil) to Jul. 2021 ($-10.82 Mil).

Advanced BioMedical Technologies's annual retained earnings declined from Oct. 2018 ($-8.63 Mil) to Oct. 2019 ($-9.58 Mil) and declined from Oct. 2019 ($-9.58 Mil) to Oct. 2020 ($-10.26 Mil).

Advanced BioMedical Technologies  (OTCPK:ABMT) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Advanced BioMedical Technologies Retained Earnings Historical Data

* Premium members only.

The historical data trend for Advanced BioMedical Technologies's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced BioMedical Technologies Retained Earnings Chart

Advanced BioMedical Technologies Annual Data
Trend Oct11 Oct12 Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.99 -7.68 -8.63 -9.58 -10.26

Advanced BioMedical Technologies Quarterly Data
Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.06 -10.26 -10.43 -10.62 -10.82

Advanced BioMedical Technologies Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $-10.82 Mil mean?
Advanced BioMedical Technologies (ABMT) has a Retained Earnings of $-10.82 Mil as of Jul. 2021. Retained earnings is the amount of net income not issued to shareholders. View historical data on Advanced BioMedical Technologies and its competitors.
Is Advanced BioMedical Technologies' Retained Earnings too high?
Advanced BioMedical Technologies' current Retained Earnings is $-10.82 Mil.
How does Advanced BioMedical Technologies' Retained Earnings compare to VYCO and ADMT?
Advanced BioMedical Technologies' Retained Earnings of $-10.82 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Medical Devices & Instruments company?
A good Retained Earnings depends on the Medical Devices & Instruments industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Advanced BioMedical Technologies and its competitors. Advanced BioMedical Technologies's current Retained Earnings is $-10.82 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced BioMedical Technologies stock overvalued right now?
Advanced BioMedical Technologies (ABMT) has a current Retained Earnings of $-10.82 Mil. The current Retained Earnings is $-10.82 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Advanced BioMedical Technologies (ABMT), the current Retained Earnings is $-10.82 Mil as of Jul. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced BioMedical Technologies Business Description

Address 535 Fifth Avenue, 4th Floor, New York, NY, USA, 10017
Advanced BioMedical Technologies Inc is engaged in designing, developing, manufacturing, and the planned future marketing of self-reinforced, re-absorbable, biodegradable internal fixation devices. The company manufactures its products using Polyamide, and it is used in a variety of applications, which include orthopaedic trauma, sports-related medical treatment, cartilage injuries, and reconstructive dental procedures. Its Polyamide products include screws, rods, and binding wires consisting of enhanced fibres and high molecular polymers, which are designed to facilitate quick healing of complex fractures in many areas of the human skeletal system.